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Managing COVID-19 related distress 
in primary care: principles of assessment 
and management
Laurence Astill Wright1* , Sam Gnanapragasam2, Anthony J. Downes1 and Jonathan I. Bisson1 
Abstract 
COVID-19 will cause normal feelings of worry and stress and many of those who experience higher levels of distress 
will experience resolution of their symptoms as society returns to pre-COVID-19 functioning. Only a minority are likely 
to develop a psychiatric disorder. Certain individuals may be vulnerable to experiencing persisting symptoms, such as 
those with pre-existing comorbidity. Management approaches could centre around using collaborative approaches 
to provide and build on already existing socioeconomic support structures, the avoidance of over-medicalisation, 
watchful waiting and finally treating those who do meet the criteria for psychiatric diagnosis. Primary care clinicians 
are likely be the first healthcare point of contact for most COVID-19 related distress and it is important that they are 
able to provide evidence based and evidence informed responses, which includes social, psychological and pharma-
cological approaches. This expert opinion paper serves to summarise some approaches, based primarily on indirect 
extrapolation of evidence concerning the general management of psychological distress, in the absence of COVID-19 
specific evidence, to assist primary care clinicians in their assessment and management of COVID-19 related distress.
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The psychological consequences of COVID-19 are likely 
to be broad and affect millions of people worldwide. 
COVID-19 may cause psychological and emotional dis-
tress, commonly manifesting in grief and in symptoms of 
anxiety, depression and traumatic stress, much of which 
will represent a normal reaction to an abnormal situation 
and subside without the need for formal intervention. 
Primary care clinicians are likely to be the first healthcare 
point of contact for most COVID-19 related distress and 
it is important that they are able to provide evidence-
informed responses, which includes social, psychologi-
cal and pharmacological approaches. This paper, which 
is based on a non-systematic review of the literature and 
expert opinion, aims to explore and predict patterns of 
psychological distress during the COVID-19 pandemic, 
including when and what interventions to offer in pri-
mary care.
Stressors, manifestations and course of distress
The trajectory of COVID-19 and magnitude of its impact 
on life across the world, suggest that the psychological 
challenges may differ from previous pandemics in scale 
and possibly also in nature via multiple psychosocial 
stressors and secondary socioeconomic consequences. 
COVID-19 may affect individuals in a variety of ways 
with direct effects on individuals (e.g., via hospitalisa-
tion and bereavement) and indirect effects (e.g., social 
isolation, financial hardship), which are compounded 
by shifting government policies (Fig.  1). As such, it is 
likely that COVID-19 will have a profound impact on 
the social determinants of health, including disruptions 
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to healthcare provision, education, economic stabil-
ity, community networks and accessibility to physical 
environment.
Some of these direct life events will meet the traumatic 
stressor criterion for Diagnostic and Statistical Manual of 
Mental Disorders Fifth Edition (DSM-5) Post traumatic 
Stress Disorder (PTSD), such as experiencing or witness-
ing actual or threatened death. However, many indirect 
stressors will not lead to PTSD but might still cause dis-
tress. Stressful life events are one of the main precipitat-
ing factors for psychopathology and COVID-19 related 
psychosocial stressors will likely precipitate a range of 
psychological reactions, including mental disorder.
It is common and normal for individuals to feel 
stressed during a time of such significant global upheaval 
(Fig. 1). For most people, this initial psychological upset 
will gradually decrease as the external stressor subsides. 
The majority of the general population will show good 
adaptability and resilience to psychosocial stressors, and 
some individuals may even have positive experiences (e.g. 
pride in their ability to cope in crisis ([1] and reduced 
anxiety amongst some adolescents [2]). Only a minority 
of individuals are likely to experience pathological dis-
tress which will probably be characterised as symptoms 
of anxiety, depression, grief, traumatic stress and mala-
daptive coping behaviours such as substance misuse [3].
These predictions are supported by the emerging evi-
dence. Recent systematic reviews and meta-analyses 
demonstrate wide ranging prevalence rates of symptoms 
of anxiety, depression and traumatic stress [4–6]. Peer 
reviewed studies of higher methodological quality dem-
onstrated lower prevalence rates of posttraumatic stress 
(17.38% in published studies) compared with those of 
lower methodological quality (34.71% in unpublished 
studies) [4]. In the United Kingdom, a study of 2000 
adults representative of the British population 52  days 
after the first confirmed case of COVID-19 demonstrated 
only slightly higher rates of traumatic stress (female: 
14.9%, male: 18.9%), anxiety (female: 25.1%, male 17.9%) 
and depression (female: 23.4%, male 20.6%) compared 
to pre-COVID-19 UK population estimates [3]. This 
highlights the remarkable psychosocial resilience of the 
Fig. 1 COVID-19 related direct and indirect causes and symptoms of psychological distress
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majority of the general population. While direct compar-
isons are not possible due to methodological differences, 
these findings are broadly similar to the prevalence of 
distress experienced during SARS-CoV-1 [7, 8].
Studies examining the psychological consequences 
of other pandemics [9] suggest that some non-specific 
symptoms of emotional distress (which have been char-
acterised as adjustment disorder—psychological distress 
in response to a significant life event – by some authors) 
will be just as common as those of PTSD [10]. COVID-
19 related mortality will also leave many people bereaved, 
experiencing entirely normal but highly distressing symp-
toms related to the anguish of losing someone close, such 
as anger, guilt, regret and loneliness. Furthermore, the 
cultural norms that support a normal grieving process 
will be disrupted (e.g., inability to attend their funeral), 
increasing the likelihood of pathological outcomes such 
as prolonged grief disorder. Loss of social support due to 
bereavement or unemployment, could add to the risk of 
individuals developing psychiatric problems and mala-
daptive coping strategies such as substance abuse.
Similar to normal feelings of worry and stress related 
to COVID-19, many of those who experience higher lev-
els of distress will experience resolution of their symp-
toms as society gradually returns to pre-COVID-19 
functioning. Only a minority may develop a psychiatric 
disorder, such as anxiety, depression, adjustment disor-
der, prolonged grief disorder and PTSD [11]. Relatively 
few studies have assessed the rate of formal psychiatric 
disorder in the general population following epidem-
ics, with most using assessment measures insufficient to 
diagnose [12] and not assessing pre-existing psychiatric 
comorbidity [11].
At risk population groups
Prevalence studies of hospitalised SARS patients have 
demonstrated a psychiatric disorder prevalence of 42.5% 
in 233 individuals up to 4 years post-infection, albeit in a 
particularly high risk group [13]. Those requiring higher 
levels of medical input for COVID-19 related illness will 
be more likely to develop psychiatric conditions requir-
ing treatment, as observed following the 2009 H1N1 
pandemic [14]. Estimates of total numbers of patients 
requiring critical care vary markedly, but of confirmed 
cases of COVID-19, however, 15% will require hospitali-
sation and 5% will require invasive mechanical ventila-
tion on an Intensive Therapy Unit [15]. The prevalence 
of PTSD symptoms following ITU discharge is 24% 
at 6  months and 22% at 12 months [16, 17], compara-
ble to that of military combat and major physical injury 
[18]. Analysis of patients treated for SARS-CoV-1 high-
lights that greater perceived life threats are associated 
with worse PTSD symptom severity [19]. This imminent 
threat to life by an entirely novel and poorly understood 
virus may be combined with worry of spreading the con-
tagious virus to vulnerable friends and family.
COVID-19 related distress will likely disproportionally 
affect those with more traumatic COVID-19 exposure 
and other more vulnerable groups, including those with 
pre-existing psychiatric and physical health comorbid-
ity [3]. As most people with pre-existing comorbidities 
are managed within community settings this will pose 
particular challenges to primary care services. Multiple 
shared vulnerability factors, such as adverse childhood 
experiences and low socioeconomic status, are common 
trans-diagnostically with pre-existing psychiatric disor-
der likely to increase susceptibility to other psychiatric 
conditions [20]. Furthermore, COVID-19 may exacerbate 
pre-existing socioeconomic vulnerability and economic 
recessions are associated with increased prevalence of 
psychiatric morbidity [21].
Healthcare workers who are predominantly female, 
may be particularly vulnerable [22], with healthcare 
workers with SARS demonstrating poor emotional 
adjustment following physical illness [12]. Clear commu-
nication and support within the workplace clearly affects 
subsequent distress, [23] and while individuals may not 
initially appreciate the severity of their distressing experi-
ences at the time, employers should consider the mental 
health consequences of inadequate support structures 
[24]. Other occupations with high viral exposure requir-
ing institutional support include supermarket workers.
Early evidence suggests that there is a higher COVID-
19 related psychological distress prevalence in women, 
who are also more likely to be bereaved [25, 26]. A mul-
titude of social and biological differences explain the 
higher rates of PTSD in women regardless of trauma type 
[27]. Women tend to seek more social support than men, 
and isolation and quarantine will decrease this available 
social support, a lack of which is the most consistent cor-
relate of poor outcomes after trauma [27]. Early reports 
of increased call volumes to the National Domestic 
Abuse Helpline [28] further highlight women’s potential 
vulnerability.
Lack of social support is likely to exacerbate distress 
related with both COVID-19-related and non-COVID-
19-related traumatic events. While isolation and quar-
antine does not meet the PTSD stressor criterion, some 
individuals may feel the experience overwhelms their 
psychological ability to cope. The psychological impacts 
of quarantine and isolation are broad and highlight the 
effect of isolation greater than 10  days in increasing 
traumatic stress symptoms, anger and avoidance [12]. 
Interestingly, early research suggests that people over 
65 report lower rates of COVID-19 related anxiety and 
depression compared to younger people, suggesting 
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greater psychosocial resilience despite higher risk of seri-
ous illness [3, 29].
Principles of intervention & treatment approaches
There remains considerable uncertainty in how best to 
manage the psychosocial consequences of COVID-19. 
This paper summarises the approaches recommended 
by a variety of organisations [1, 30], based primarily on 
the indirect extrapolation of evidence concerning the 
general management of psychological distress, in the 
absence of COVID-19 specific evidence. The large het-
erogeneity in demographics affected by COVID-19 will 
cause varied manifestations of psychological distress 
requiring a range of approaches (Fig.  2). General over-
arching principles are centred around the avoidance of 
over-medicalisation and further harm, using collabora-
tive approaches to provide and build on already existing 
socioeconomic support structures, watchful waiting and 
finally treating those who do meet the criteria for psy-
chiatric diagnosis [1]. Stepped care interventions should 
be multi-faceted and function within an integrated sup-
port system of multiple coordinating groups acting in 
response to COVID-19 [1].
Initially, individuals will require easy access to basic 
services providing practical and financial security 
to protect their health and wellbeing. These services 
should be safe, socially appropriate, preserve the dig-
nity of those accessing them and be able to adapt to 
changing needs [1], e.g. ensuring vulnerable groups 
still retain access to shelter, care and medication. Fol-
lowing this, the COVID-19 response should seek to 
enable and extend existing family and community 
support structures through providing COVID-19 spe-
cific knowledge, teaching new supportive skills (such 
as psychological first aid) and increasing awareness of 
the care pathways in place for distressed individuals to 
access specialist support [1]. Employers of staff vulner-
able to psychological distress should implement clear 
guidance around policies, practices and occupational 
support structures [31] and avoid stigmatising those 
with COVID-19 or related distress [30].
For those individuals displaying heightened distress, 
primary care practitioners can offer emotional, practical 
and pragmatic support. This serves to cope with wor-
ries arising directly from COVID-19 (e.g., exposure to 
the disease and survivors’ stories of suffering, loneliness 
and powerlessness) and those indirectly related (e.g., an 
inability to engage in recreation, poor organisation and 
occupational role definitions) [31]. Individuals should 
be encouraged to maintain the social support struc-
tures and coping strategies they already possess within 
the confines of social distancing [30] but there is no one 
size fits all solution to the psychosocial requirements of 
an entire society [1]. Coping strategies may include self-
care techniques, such as relaxation and cognitive exer-
cises, physical exercise and providing support on how 
to access reliable information about COVID-19 related 
developments.
COVID‑19 related mental illness
The ability to distinguish between a normal reaction to 
external stressors and a pathological one will be key for 
primary care practitioners, who may already struggle to 
differentiate between psychological distress and mental 
Fig. 2 Intervention pyramid for mental health and psychosocial support (Reproduced from IASC 2020—permission has been requested to 
reproduce this figure)
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disorder due to contrasting frameworks around the 
conceptualisation of each [32]. This may be particularly 
challenging acutely, before the possibility of longitudi-
nal assessment and before any basic supportive inter-
ventions have been offered [33]. Pathological reactions 
typically involve a significant impact on an individual’s 
functioning with a higher severity of symptoms persist-
ing over a prolonged period of time and often beyond 
the resolution of a precipitating psychosocial stressor. 
Pathological reactions may be associated with higher 
degrees of risk, the management of which should be a 
key consideration during initial consultation. Assess-
ment should appreciate that while direct COVID-19 
stressors may resolve first, for many, the indirect impact 
of the pandemic, such as financial hardship, will persist 
for longer.
For the small minority of individuals who develop signs 
and symptoms of mental disorder and for whom basic 
emotional and pragmatic support is insufficient, evi-
dence-based psychological and/or pharmacological treat-
ments should be offered based on the primary presenting 
diagnosis (e.g. Depression [33], PTSD [34]). Many of 
these interventions will be provided in primary care set-
tings but some individuals will have more complex dif-
ficulties or risks, including suicide risk, that require 
involvement of secondary care services.
Limitations
This paper, which is not the result of a systematic litera-
ture search, is based on a non-systematic review of the 
literature and our knowledge of the area, serves to sum-
marise some of the available evidence to assist primary 
care clinicians in their assessment and management of 
COVID-19 related distress. Consistent with a recently 
published rapid systematic review of the literature [35], 
most of the studies considered have limited internal and 
external validity and a high risk of selection bias (small 
sample sizes from single geographical regions with short 
follow up periods). Consequently, our recommendations 
should be employed judiciously and always in a person-
alised manner that integrates clinical expertise, indi-
vidual patients’ values and preferences, and the available 
evidence.
Conclusions
COVID-19 related distress may manifest in symptoms of 
depression, anxiety, grief and traumatic stress, the major-
ity of which does not require formal medical treatment. 
Those particularly vulnerable to persisting symptoms 
and the development of psychiatric conditions are those 
with pre-existing conditions, females, health care work-
ers, those with low social support, possibly exacerbated 
by isolation and quarantine, and those facing indirect 
socioeconomic consequences such as unemployment. 
For those who develop mental health disorders, effective 
evidence-based treatments are available. The psychiatric 
consequences of the COVID-19 pandemic will likely first 
present in primary care and primary care clinicians have 
the potential to mitigate their consequences.
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